Therefore, KETO, when managed carefully, contributes to fat breakdown and enhanced insulin signaling, thus counteracting the onset and progression of steatotic liver disease [267] while concomitantly improving associated comorbidities like obesity and T2DM. The gene discussed is INS; the disease is obesity disorder.